These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 12481375)

  • 1. Analysis of the drugs, applied for the treatment of the patients, hospitalized in a urological department, by pharmacological groups.
    Dimitrov D; Petkova V
    Boll Chim Farm; 2002; 141(5):348-54. PubMed ID: 12481375
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the drugs, applied for the treatment of the patients, hospitalized in a urological department, by pharmacological groups.
    Dimitrov D
    Boll Chim Farm; 2001; 140(4):272-8. PubMed ID: 11570226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic prophylaxis in urology and rationalization of the antibiotics policy in a urological ward].
    Boerema JB; Debruyne FM; Hekster YA
    Ned Tijdschr Geneeskd; 1982 Sep; 126(39):1770-4. PubMed ID: 7144937
    [No Abstract]   [Full Text] [Related]  

  • 4. Urodynamic referral centres.
    Stephenson T
    Urol Clin North Am; 1979 Feb; 6(1):161-6. PubMed ID: 432988
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment to «Costs and hospital procedures in an urology department of a tertiary hospital. Analysis of groups related by their diagnosis».
    González-Enguita C
    Actas Urol Esp; 2017; 41(6):409-410. PubMed ID: 27955858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Economic prescription of drugs].
    Sonne J; Faber O
    Ugeskr Laeger; 2004 Apr; 166(18):1695. PubMed ID: 15174414
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 9. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug costs in departments of internal medicine. An analysis of costs for patients and departments].
    Rabøl R; Kolbye A; Andersen SE
    Ugeskr Laeger; 2003 Apr; 165(15):1565-8. PubMed ID: 12715661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correct drug utilization--a national economy perspective].
    Jørgensen E
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):934. PubMed ID: 16554889
    [No Abstract]   [Full Text] [Related]  

  • 12. [Limits for how much are we prepared to pay for drugs].
    Harild M
    Ugeskr Laeger; 2003 Oct; 165(41):3940. PubMed ID: 14579560
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost comparison of hand assisted laparoscopic nephrectomy and open nephrectomy: analysis of individual parameters.
    Lotan Y; Duchene DA; Cadeddu JA; Koeneman KS
    J Urol; 2003 Sep; 170(3):752-5. PubMed ID: 12913690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Creation of the 1st French hospital urological site on the Internet].
    Pagès F; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1996; 102(5-6):246. PubMed ID: 9833034
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
    Andreasen J
    Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of the reimbursement scheme on the consumption of drugs].
    Madsen UK
    Ugeskr Laeger; 2009 Mar; 171(10):783-6. PubMed ID: 19265600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical waste generation from renal units: implications and solutions.
    Hoenich NA; Levin R; Pearce C
    Semin Dial; 2005; 18(5):396-400. PubMed ID: 16191180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An innovative cooperative model between a department of urology and a urological medical specialist practice].
    Schick V; Penkert A
    Urologe A; 2004 Jan; 43(1):13-5. PubMed ID: 14747921
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiepileptic treatment nearly six times more expensive since 1990].
    Persson PM; Russom A; Tomson T
    Lakartidningen; 2003 Jan; 100(1-2):42-6. PubMed ID: 12572136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.